Metric 15: Percentage of patients with aneurysmal SAH started on nimodipine 60 mg every 4 hours within 24 hours of diagnosis and treated until 21 days post hemorrhage.
{"Image DocumentName": "Metric 15: Percentage of patients with aneurysmal SAH started on nimodipine 60 mg every 4 hours within 24 hours of diagnosis and treated until 21 days post hemorrhage.", "Image ImageDescription": "Nimodipine has been shown to be beneficial in randomized controlled trials by reducing the incidence and severity of ischemic deficits in patients with SAH from a ruptured aneurysm. Patients may be given a reduced dose if there is associated hypotension with the medication. \u00a92011 American Heart Association, Inc. All rights reserved. Leifer et al. Published online in Stroke Jan. 13, 2011.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}